The p21‐activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Pharmacology

• Publication date

  2017-06-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.13872PMID 28574147PMCID PMC5867015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.

  2017cited by this paper
• Essential role of Cdc42 in cardiomyocyte proliferation and cell-cell adhesion during heart development.

  2017cited by this paper
• Structure, biochemistry, and biology of PAK kinases.

  2017cited by this paper
• Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3

  2017cited by this paper
• The p21‐activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration

  2017cited by this paper
• Effect of sphingosine-1-phosphate on L-type calcium current and Ca2+ transient in rat ventricular myocytes

  2016cited by this paper
• Rac1-PAK2 pathway is essential for zebrafish heart regeneration.

  2016cited by this paper
• PAKs in Human Cancer Progression: From Inception to Cancer Therapeutic to Future Oncobiology.

  2016cited by this paper
• Cardiomyocyte specific deletion of PP2A causes cardiac hypertrophy.

  2016cited by this paper
• Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection.

  2016cited by this paper
• A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy

  2016cited by this paper
• ArgBP2γ interacts with Akt and p21-activated kinase-1 and promotes cell survival.

  2016cited by this paper
• Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway

  2016cited by this paper
• FBXO32, encoding a member of the SCF complex, is mutated in dilated cardiomyopathy

  2016cited by this paper
• MicroRNA-137 Negatively Regulates H2O2-Induced Cardiomyocyte Apoptosis Through CDC42

  2015cited by this paper
• Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.

  2015influential reference
• The Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels

  2015cited by this paper
• Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases

  2015influential reference
• Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes.

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Progressive age-associated activation of JNK associates with conduction disruption in the aged atrium

  2015cited by this paper
• Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32

  2015cited by this paper
• Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart

  2015cited by this paper
• miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy.

  2015cited by this paper
• Real-time relationship between PKA biochemical signal network dynamics and increased action potential firing rate in heart pacemaker cells: Kinetics of PKA activation in heart pacemaker cells.

  2015cited by this paper
• Stimulation of ICa by basal PKA activity is facilitated by caveolin-3 in cardiac ventricular myocytes☆

  2014cited by this paper
• Mkk4 Is a Negative Regulator of the Transforming Growth Factor Beta 1 Signaling Associated With Atrial Remodeling and Arrhythmogenesis With Age

  2014cited by this paper
• Participation of group I p21-activated kinases in neuroplasticity.

  2014cited by this paper
• Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation.

  2014cited by this paper
• Pak1 Is Required to Maintain Ventricular Ca 2+ Homeostasis and Electrophysiological Stability Through SERCA2a Regulation in Mice

  2014cited by this paper
• Inhibition of Angiotensin II-Induced Cardiac Hypertrophy and Associated Ventricular Arrhythmias by a p21 Activated Kinase 1 Bioactive Peptide

  2014cited by this paper
• Inhibition of JNK Aggravates the Recovery of Rat Hearts after Global Ischemia: The Role of Mitochondrial JNK

  2014cited by this paper
• PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to β-adrenergic signaling.

  2014cited by this paper
• Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: Role of autophagy

  2014cited by this paper
• Role of p21-activated kinases in cardiovascular development and function

  2013cited by this paper
• A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin

  2013cited by this paper
• TGF&bgr; receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells

  2013cited by this paper
• Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1.

  2013influential reference
• A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis from Pressure Overload by Targeting NFAT Signaling and Periostin

  2013cited by this paper
• Protein phosphatase 2A effectively modulates basal L-type Ca(2+) current by dephosphorylating Ca(v)1.2 at serine 1866 in mouse cardiac myocytes.

  2012cited by this paper
• p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation.

  2012influential reference
• Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling

  2012cited by this paper
• Chronic receptor-mediated activation of Gi/o proteins alters basal t-tubular and sarcolemmal L-type Ca²⁺ channel activity through phosphatases in heart failure.

  2012cited by this paper
• Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart

  2011cited by this paper
• Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload.

  2011cited by this paper
• Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.

  2011cited by this paper
• c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.

  2011cited by this paper
• Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury

  2011cited by this paper
• cAMP-stimulated Protein Phosphatase 2A Activity Associated with Muscle A Kinase-anchoring Protein (mAKAP) Signaling Complexes Inhibits the Phosphorylation and Activity of the cAMP-specific Phosphodiesterase PDE4D3*

  2010influential reference
• Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma

  2010cited by this paper
• Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

  2010cited by this paper
• Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase

  2010cited by this paper
• Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.

  2010cited by this paper
• FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.

  2010cited by this paper
• Phosphoinositides are essential coactivators for p21-activated kinase 1.

  2010cited by this paper
• PAK1 as a therapeutic target

  2010cited by this paper
• Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.

  2009cited by this paper
• Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.

  2009cited by this paper
• Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure Overloading

  2009cited by this paper
• Cdc42 is an antihypertrophic molecular switch in the mouse heart.

  2009influential reference
• Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling but Not in Physiological Cardiac Growth

  2009cited by this paper
• Ablation of Ventricular Myosin Regulatory Light Chain Phosphorylation in Mice Causes Cardiac Dysfunction in Situ and Affects Neighboring Myofilament Protein Phosphorylation*

  2009cited by this paper
• Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes.

  2009cited by this paper
• Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation*

  2009cited by this paper
• Does Contractile Ca2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes?

  2008cited by this paper
• Regulation of cardiac excitation and contraction by p21 activated kinase-1.

  2008cited by this paper
• Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.

  2008influential reference
• Genetic Manipulation of Periostin Expression in the Heart Does Not Affect Myocyte Content, Cell Cycle Activity, or Cardiac Repair

  2008cited by this paper
• Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart

  2008cited by this paper
• Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.

  2008influential reference
• Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling

  2007cited by this paper
• Regulation of L-Type Calcium Channel and Delayed Rectifier Potassium Channel Activity by p21-Activated Kinase-1 in Guinea Pig Sinoatrial Node Pacemaker Cells

  2007cited by this paper
• The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.

  2007cited by this paper
• A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.

  2007cited by this paper
• Cofilin activity downstream of Pak1 regulates cell protrusion efficiency by organizing lamellipodium and lamella actin networks.

  2007cited by this paper
• p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility.

  2007cited by this paper
• Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling

  2007cited by this paper
• Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster.

  2006cited by this paper
• Cardiovascular actions of berberine.

  2006cited by this paper
• Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.

  2006cited by this paper
• JNK1 is required to preserve cardiac function in the early response to pressure overload.

  2006cited by this paper
• A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.

  2006cited by this paper
• Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats.

  2006cited by this paper
• p21-Activated Kinase 1 Regulates Microtubule Dynamics by Phosphorylating Tubulin Cofactor B

  2005cited by this paper
• Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction.

  2005cited by this paper
• The active conformation of the PAK1 kinase domain.

  2005cited by this paper
• p21-activated Kinase 1 (Pak1)-dependent Phosphorylation of Raf-1 Regulates Its Mitochondrial Localization, Phosphorylation of BAD, and Bcl-2 Association*

  2005cited by this paper
• ArgBP2γ Interacts with Akt and p21-activated Kinase-1 and Promotes Cell Survival*

  2005cited by this paper
• The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A.

  2005cited by this paper
• Targeted Activation of c-Jun N-terminal Kinase in Vivo Induces Restrictive Cardiomyopathy and Conduction Defects*[boxs]

  2004cited by this paper
• L-Type Ca 2 Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases

  2004cited by this paper
• Overexpression of the Catalytic Subunit of Protein Phosphatase 2A Impairs Cardiac Function*

  2004cited by this paper
• Regulation of Microtubule Destabilizing Activity of Op18/Stathmin Downstream of Rac1*

  2004cited by this paper
• p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells*

  2004cited by this paper
• Role of Rho/ROCK and p38 MAP Kinase Pathways in Transforming Growth Factor-β-mediated Smad-dependent Growth Inhibition of Human Breast Carcinoma Cells in Vivo*

  2004cited by this paper
• Intracellular Localization and Functional Effects of P21-Activated Kinase-1 (Pak1) in Cardiac Myocytes

  2004influential reference
• Cell surface receptors activate p21-activated kinase 1 via multiple Ras and PI3-kinase-dependent pathways.

  2003cited by this paper
• Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation.

  2003cited by this paper
• Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells

  2003cited by this paper

• PAK4 in metabolic diseases: regulation by nutrient signals and therapeutic implications.

  2026cites this paper
• Research status and molecular mechanisms of disulfidptosis in cardiovascular diseases (Review)

  2026cites this paper
• Endothelial TBK1 Deficiency Inhibits Endothelial-to-Mesenchymal Transition and Atherogenesis Through Suppressing PAK1/ERK1/2 Signaling.

  2026cites this paper
• Interplay of PAK1 and CAMKII in Pancreatic Beta Cell Insulin Secretion

  2025cites this paper
• p21‐Activated Kinase 1 (Pak1) as an Element in Functional and Dysfunctional Interplay Among the Myocardium, Adipose Tissue, and Pancreatic Beta Cells

  2025cites this paper
• Modulating PAK1: Accessory Proteins as Promising Therapeutic Targets

  2025cites this paper
• The Important Role of p21-Activated Kinases in Pancreatic Exocrine Function

  2025cites this paper
• Thrombospondin-4 regulates apoptosis of vascular smooth muscle cells after artery transplanted into vein

  2025cites this paper
• Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation

  2025influential citation
• Altered Protein Phosphorylation in a Novel Midbrain Organoid Model for Bipolar Disorder

  2025cites this paper
• Cardiac arrhythmogenesis: roles of ion channels and their functional modification

  2024cites this paper
• Regulation of Vascular Injury and Repair by P21-Activated Kinase 1 and P21-Activated Kinase 2: Therapeutic Potential and Challenges

  2024cites this paper
• Spatio‐temporal localization of P21‐activated kinase in endometrial cancer

  2024cites this paper
• Desmin and its molecular chaperone, the αB-crystallin: How post-translational modifications modulate their functions in heart and skeletal muscles?

  2023cites this paper
• P-21 Activated Kinases in Liver Disorders

  2023cites this paper
• Cardiomyocyte electrophysiology and its modulation: current views and future prospects

  2023cites this paper
• Targeting p21-activated kinase 1 for development of a novel anti-arrhythmic drug class

  2023cites this paper
• The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease.

  2022cites this paper
• Ivermectin : An Effective Remedy Against Various Diseases : A Literature Review

  2022cites this paper
• p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity

  2022influential citation
• 2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system.

  2021cites this paper
• P21-activated kinase 1 mediates angiotensin II-induced differentiation of human atrial fibroblasts via the JNK/c-Jun pathway

  2021cites this paper
• Pak1 kinase regulates ribonucleoprotein granules through Sts5 for polarized growth and the glucose starvation response

  2021cites this paper
• The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?

  2021cites this paper
• CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42

  2021cites this paper
• Pak1 kinase controls cell shape through ribonucleoprotein granules

  2021cites this paper
• p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.

  2021cites this paper
• PAK1 Silencing Attenuated Proinflammatory Macrophage Activation and Foam Cell Formation by Increasing PPARγ Expression

  2021cites this paper
• Association between miR-492 rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children

  2020cites this paper
• circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis

  2020cites this paper
• Fibrinogen Activates PAK1/Cofilin Signaling Pathway to Protect Endothelial Barrier Integrity

  2020influential citation
• Knockdown of miR-665 Protects Against Cardiomyocyte Ischemia/Reperfusion Injury-Induced ROS Accumulation and Apoptosis Through the Activation of Pak1/Akt Signaling in Myocardial Infarction.

  2020cites this paper
• Phosphoproteomic analysis of STRIPAK mutants identifies a conserved serine phosphorylation site in PAK kinase CLA4 to be important in fungal sexual development and polarized growth

  2020cites this paper
• Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis

  2019cites this paper
• Cardiovascular Effects Mediated by Imidazoline Drugs: an Update.

  2019cites this paper
• iTRAQ-based proteomic and phosphoproteomic analyses of STRIPAK mutants from the fungus Sordaria macrospora identifies a conserved serine phosphorylation site in PAK kinase CLA4 to be important for sexual development and polarized growth

  2019cites this paper
• Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma

  2019cites this paper
• Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass

  2019cites this paper
• Spotlight on small molecules in cardiovascular diseases

  2018influential citation
• Isoproterenol‐induced cardiac ischemia and fibrosis: Plant‐based approaches for intervention

  2018cites this paper
• Inhibition of p21‐activated kinase 1 attenuates the cardinal features of asthma through suppressing the lymph node homing of dendritic cells

  2018cites this paper
• The p21‐activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration

  2017cites this paper